Literature DB >> 25896708

Characterization of pre-antibiotic era Klebsiella pneumoniae isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella.

Matthew E Wand1, Kate S Baker2, Gabriel Benthall3, Hannah McGregor4, James W I McCowen3, Ana Deheer-Graham4, J Mark Sutton3.   

Abstract

The EGD Murray collection consists of approximately 500 clinical bacterial isolates, mainly Enterobacteriaceae, isolated from around the world between 1917 and 1949. A number of these "Murray" isolates have subsequently been identified as Klebsiella pneumoniae. Antimicrobial susceptibility testing of these isolates showed that over 30% were resistant to penicillins due to the presence of diverse blaSHV β-lactamase genes. Analysis of susceptibility to skin antiseptics and triclosan showed that while the Murray isolates displayed a range of MIC/minimal bactericidal concentration (MBC) values, the mean MIC value was lower than that for more modern K. pneumoniae isolates tested. All Murray isolates contained the cation efflux gene cepA, which is involved in disinfectant resistance, but those that were more susceptible to chlorhexidine were found to have a 9- or 18-bp insertion in this gene. Susceptibility to other disinfectants, e.g., H2O2, in the Murray isolates was comparable to that in modern K. pneumoniae isolates. The Murray isolates were also less virulent in Galleria and had a different complement of putative virulence factors than the modern isolates, with the exception of an isolate related to the modern lineage CC23. More of the modern isolates (41% compared to 8%) are classified as good/very good biofilm formers, but there was overlap in the two populations. This study demonstrated that a significant proportion of the Murray Klebsiella isolates were resistant to penicillins before their routine use. This collection of pre-antibiotic era isolates may provide significant insights into adaptation in K. pneumoniae in relation to biocide susceptibility.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896708      PMCID: PMC4468732          DOI: 10.1128/AAC.05009-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.

Authors:  Christoph Lübbert; Norman Lippmann; Thilo Busch; Udo X Kaisers; Tanja Ducomble; Tim Eckmanns; Arne C Rodloff
Journal:  Am J Infect Control       Date:  2014-04       Impact factor: 2.918

2.  Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella.

Authors:  José Luis Insua; Enrique Llobet; David Moranta; Camino Pérez-Gutiérrez; Anna Tomás; Junkal Garmendia; José A Bengoechea
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

3.  Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation.

Authors:  Matthew E Wand; Lucy J Bock; Jane F Turton; Philip G Nugent; J Mark Sutton
Journal:  J Med Microbiol       Date:  2011-12-22       Impact factor: 2.472

4.  Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy.

Authors:  M Giuffrè; C Bonura; D M Geraci; L Saporito; R Catalano; S Di Noto; F Nociforo; G Corsello; C Mammina
Journal:  J Hosp Infect       Date:  2013-09-08       Impact factor: 3.926

5.  Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan.

Authors:  L Kristopher Siu; Chang-Phone Fung; Feng-Yee Chang; Nelson Lee; Kuo-Ming Yeh; Tse Hsien Koh; Margaret Ip
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

6.  Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacΔE and qacE efflux pump genes and antibiotic resistance.

Authors:  A Abuzaid; A Hamouda; S G B Amyes
Journal:  J Hosp Infect       Date:  2012-04-11       Impact factor: 3.926

Review 7.  Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation.

Authors:  Caitlin N Murphy; Steven Clegg
Journal:  Future Microbiol       Date:  2012-08       Impact factor: 3.165

8.  Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis.

Authors:  Matthew E Wand; Claudia M Müller; Richard W Titball; Stephen L Michell
Journal:  BMC Microbiol       Date:  2011-01-17       Impact factor: 3.605

9.  The uncertain consequences of transferring bacterial strains between laboratories - rpoS instability as an example.

Authors:  Beny Spira; Rodrigo de Almeida Toledo; Ram P Maharjan; Thomas Ferenci
Journal:  BMC Microbiol       Date:  2011-11-08       Impact factor: 3.605

10.  Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates.

Authors:  Sissel Skovgaard; Lene Nørby Nielsen; Marianne Halberg Larsen; Robert Leo Skov; Hanne Ingmer; Henrik Westh
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more
  20 in total

Review 1.  Looking Backward To Move Forward: the Utility of Sequencing Historical Bacterial Genomes.

Authors:  Rebecca J Bennett; Kate S Baker
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

2.  Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Authors:  Matthew E Wand; Lucy J Bock; Laura C Bonney; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 3.  Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae.

Authors:  C Hennequin; F Robin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

4.  A Descriptive Study of Chlorhexidine as a Disinfectant in Cleft Palate Surgery.

Authors:  Gieljam Johannes Roode; Kurt-Wilhelm Bütow
Journal:  Clin Med Res       Date:  2018-05-03

5.  Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae.

Authors:  Bradley R Clarke; Olga G Ovchinnikova; Steven D Kelly; Monica L Williamson; Jennifer E Butler; Bin Liu; Lu Wang; Xi Gou; Rainer Follador; Todd L Lowary; Chris Whitfield
Journal:  J Biol Chem       Date:  2018-02-12       Impact factor: 5.157

6.  Epidemiology and microbiological characterization of clinical isolates of Staphylococcus aureus in a single healthcare region of the UK, 2015.

Authors:  C Horner; L Utsi; L Coole; M Denton
Journal:  Epidemiol Infect       Date:  2016-10-28       Impact factor: 4.434

7.  The diversity of Klebsiella pneumoniae surface polysaccharides.

Authors:  Rainer Follador; Eva Heinz; Kelly L Wyres; Matthew J Ellington; Michael Kowarik; Kathryn E Holt; Nicholas R Thomson
Journal:  Microb Genom       Date:  2016-08-25

8.  Identification of Klebsiella capsule synthesis loci from whole genome data.

Authors:  Kelly L Wyres; Ryan R Wick; Claire Gorrie; Adam Jenney; Rainer Follador; Nicholas R Thomson; Kathryn E Holt
Journal:  Microb Genom       Date:  2016-12-12

9.  The Murray collection of pre-antibiotic era Enterobacteriacae: a unique research resource.

Authors:  Kate S Baker; Edward Burnett; Hannah McGregor; Ana Deheer-Graham; Christine Boinett; Gemma C Langridge; Alexander M Wailan; Amy K Cain; Nicholas R Thomson; Julie E Russell; Julian Parkhill
Journal:  Genome Med       Date:  2015-09-28       Impact factor: 11.117

10.  Simple and rapid sample preparation system for the molecular detection of antibiotic resistant pathogens in human urine.

Authors:  Martha Valiadi; Sumit Kalsi; Isaac G F Jones; Carrie Turner; J Mark Sutton; Hywel Morgan
Journal:  Biomed Microdevices       Date:  2016-02       Impact factor: 2.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.